Reactivation of PAX2 expression in RCC correlates with the anti-apoptotic capacity of RCC cells, while its inhibition helps to promote RCC cell apoptosis and sensitization to chemotherapy drugs such as cisplatin [22,31]. The gene discussed is PAX2; the disease is renal cell carcinoma.